Roxithromycin

Producer:Zhejiang Guobang Pharmaceutical Co., Ltd. mainly produces and operates pharmaceutical raw materials, chemical intermediates and veterinary drugs. Guobang Pharmaceutical adheres to the business direction of ensuring quality by profession and reflecting efficiency by scale. The whole enterprise has passed the ISO9001: 2000 quality system and ISO14001 environmental quality system certification. All products are produced in strict accordance with ICH Q7A standard and have passed the domestic GMP certification. The American DMF and European DMF, which have independently prepared drugs, have the production capacity and market share of a single product reaching more than 30% of similar products in China. Among them, the quinolones such as ciprofloxacin, enrofloxacin, levofloxacin, and macrolides such as azithromycin, clarithromycin, and roxithromycin have more important shares in the domestic and foreign markets. 40% of the products are sold to the international market, and they have conducted in-depth and extensive cooperation with many pharmaceutical enterprises in Europe and the United States.

Staff:1157 persons

Registered capital:138.8 million

Producer:Huangshi Shixing Pharmaceutical Co., Ltd., formerly known as Huangshi No.4 Pharmaceutical Factory. The main products are erythromycin ethylsuccinate, erythromycin etoposide, azithromycin, hydroxybenzazole hydrochloride, dextroketoprofen, dextroketoprofen tromethamine, cinepazide maleate.

Staff:300-399 persons

Registered capital:100 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978